- Home
- GEOS vs PLRX Comparison
GEOS vs PLRX Comparison
Compare GEOS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEOS
- PLRX
- Stock Information
- Founded
- GEOS 1980
- PLRX 2015
- Country
- GEOS United States
- PLRX United States
- Employees
- GEOS N/A
- PLRX N/A
- Industry
- GEOS Industrial Machinery/Components
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- GEOS Industrials
- PLRX Health Care
- Exchange
- GEOS Nasdaq
- PLRX Nasdaq
- Market Cap
- GEOS 72.9M
- PLRX 77.3M
- IPO Year
- GEOS 1997
- PLRX 2020
- Fundamental
- Price
- GEOS $12.40
- PLRX $1.40
- Analyst Decision
- GEOS
- PLRX Hold
- Analyst Count
- GEOS 0
- PLRX 10
- Target Price
- GEOS N/A
- PLRX $9.79
- AVG Volume (30 Days)
- GEOS 503.2K
- PLRX 1.6M
- Earning Date
- GEOS 08-07-2025
- PLRX 08-06-2025
- Dividend Yield
- GEOS N/A
- PLRX N/A
- EPS Growth
- GEOS N/A
- PLRX N/A
- EPS
- GEOS N/A
- PLRX N/A
- Revenue
- GEOS $116,542,000.00
- PLRX N/A
- Revenue This Year
- GEOS N/A
- PLRX N/A
- Revenue Next Year
- GEOS N/A
- PLRX N/A
- P/E Ratio
- GEOS N/A
- PLRX N/A
- Revenue Growth
- GEOS N/A
- PLRX N/A
- 52 Week Low
- GEOS $5.51
- PLRX $1.10
- 52 Week High
- GEOS $18.99
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- GEOS 55.56
- PLRX 54.68
- Support Level
- GEOS $12.60
- PLRX $1.13
- Resistance Level
- GEOS $14.38
- PLRX $1.27
- Average True Range (ATR)
- GEOS 1.80
- PLRX 0.11
- MACD
- GEOS -0.32
- PLRX 0.02
- Stochastic Oscillator
- GEOS 38.67
- PLRX 90.00
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.